A detailed history of Wealth Spring Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wealth Spring Partners, LLC holds 2,656 shares of NVS stock, worth $276,967. This represents 0.2% of its overall portfolio holdings.

Number of Shares
2,656
Previous 2,656 -0.0%
Holding current value
$276,967
Previous $268 Million 0.94%
% of portfolio
0.2%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

SELL
$92.52 - $104.91 $21,834 - $24,758
-236 Reduced 8.16%
2,656 $268 Million
Q1 2023

May 03, 2023

SELL
$80.03 - $92.81 $7,842 - $9,095
-98 Reduced 3.28%
2,892 $266 Million
Q4 2022

Feb 09, 2023

SELL
$75.55 - $92.52 $37,775 - $46,260
-500 Reduced 14.33%
2,990 $271 Million
Q3 2022

Feb 08, 2023

BUY
$74.61 - $87.26 $260,388 - $304,537
3,490 New
3,490 $265 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wealth Spring Partners, LLC Portfolio

Follow Wealth Spring Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Spring Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Spring Partners, LLC with notifications on news.